[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354586-105":59,"doc-detail-354586-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","chemotherapeutic-potential-of-fluorouracil-platinum-iv-prodrugs-against-cisplatin-resistant-colorectal-cancer-cells","Chemotherapeutic Potential of Fluorouracil-Platinum (IV) Prodrugs Against Cisplatin-Resistant Colorectal Cancer Cells","","Fluorouracil-platinum(IV) prodrugs are presented as a multimechanistic chemotherapeutic strategy with improved anticancer activity. PtIVP-5FUMeOBut and PtIV56-5FUMeOBut are synthesized by derivatizing 5-fluorouracil and coordinating it to platinum(IV), supported by the cytotoxicity of platinum(II) precursors. In vitro experiments in colorectal cancer models compare cellular uptake and cytotoxicity in 3D spheroids, alongside cisplatin and 5FU. Mechanisms are probed via ROS, mitochondrial membrane potential, cell-cycle progression, apoptosis/necrosis assays, proteomic profiling, and western blots.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chemotherapeutic-potential-of-fluorouracil-platinum-iv-prodrugs-against-cisplatin-resistant-colorectal-cancer-cells/354586/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chemotherapeutic-potential-of-fluorouracil-platinum-iv-prodrugs-against-cisplatin-resistant-colorectal-cancer-cells/354586.png","ImageObject",300,407,{"name":92,"@type":93},"nayy☆","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What prodrugs are evaluated in this study and how are they designed?","Question",{"text":112,"@type":113},"PtIVP-5FUMeOBut and PtIV56-5FUMeOBut are created by derivatizing 5-fluorouracil and coordinating it to platinum(IV) complexes to combine 5FU’s antimetabolite effects with platinum-based cytotoxicity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which in vitro models and comparisons are used to assess anticancer activity?",{"text":117,"@type":113},"The study evaluates in vitro potency in colorectal cancer models, including cellular uptake, cytotoxicity, and effects in 3D spheroid cultures, comparing results with cisplatin and 5FU.",{"name":119,"@type":110,"acceptedAnswer":120},"How are the mechanisms of action investigated?",{"text":121,"@type":113},"Mechanistic work includes assays for apoptosis and necrosis, measurements related to reactive oxygen species and mitochondrial membrane potential, cell-cycle progression analysis, proteomic profiling, and western blot analysis of key signaling pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354586,1790322497,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Chemistry –AEuropean Journal  \nRESEARCH ARTICLE   \nChemotherapeutic Potential of Fluorouracil-Platinum (IV) Prodrugs Against Cisplatin-Resistant Colorectal Cancer Cells  \nMaria George Elias1, 2, 3   Aleen Khoury1   Shadma Fatima3   Timothy J. Mann2, 3   Shawan Karan1    \nMeena Mikhael4   Paul de Souza5   Christopher P. Gordon1   Kieran F. Scott2, 3   Janice R. Aldrich-Wright1, 2   \n1 Faculty of Engineering, Computing and Science, Western Sydney University, Sydney, New South Wales, Australia  2 Faculty of Health, School of Medicine, Western Sydney University, Sydney, New South Wales, Australia  3Medical Oncology, Ingham Institute for Applied Medical Research, Liverpool Hospital, Liverpool, New South Wales, Australia  4Mass Spectrometry Facility, Western Sydney University, Sydney, New South Wales, Australia  5Nepean Clinical  \nSchool, Faculty of Medicine and Health, University of Sydney, Kingswood, New South Wales, Australia Correspondence: Janice R. Aldrich-Wright ([j.aldrich-wright@westernsydney.edu.au](j.aldrich-wright@westernsydney.edu.au))  \nReceived: 13 November 2025  Revised: 1 February 2026  Accepted: 18 February 2026  \nKeywords: apoptosis | cytoskeleton | cytotoxicity | fluorouracil | platinum(II) | platinum(IV)  \nABSTRACT  \nFluorouracil-platinum(IV) prodrugs represent a novel class of multimechanistic chemotherapeutics with enhanced anticancer potential. The prodrugs PtIVP-5FUMeOBut and PtIV56-5FUMeOBut were actualized by derivatising the clinical drug 5-fluorouracil (5FU) and coordinating it to platinum(IV) complexes, leveraging the established cytotoxicity of their platinum(II) precursors, PtIIPHENSS and PtII56MESS. The rationale behind this design is to combine the DNA synthesis-disrupting antimetabolite activity of 5FU with platinum-based cytotoxicity, aiming to enhance therapeutic efficacy. This study evaluates the in vitro potency of PtIVP-5FUMeOBut and PtIV56-5FUMeOBut in colorectal cancer models, assessing their cellular uptake, cytotoxicity, and effects in 3D spheroid cultures. Comparative analyses with cisplatin and 5FU explore their impact on cell survival, reactive oxygen species production, mitochondrial membrane potential, and cell-cycle progression. Mechanistic insights are further examined through apoptosis and necrosis assays, proteomic profiling, and western blot analysis of key signalling pathways. These findings contribute to the preclinical development of fluorouracil-platinum(IV) prodrugs as potential candidates for cancer therapy.  \n1  Introduction  \nColorectal cancers (CRC), encompassing both colon and rectal cancers, rank second in cancer-related mortality and are the third most diagnosed cancers in the United States [1, 2] . Early-stage colon cancer is typically treated with surgery, often followed by adjuvant chemotherapy using agents such as fluorouracil and cisplatin. However, recurrence and resistance to these drugs remain major clinical challenges [2–9] . Overcoming resistance to standard treatments like cisplatin is  \nessential to improving therapeutic efficacy and extending patient survival.  \nMedicinal inorganic chemistry leverages the unique properties of metals for disease diagnosis and treatment. Metal ions, which readily form cations, can interact with negatively charged biological molecules, enabling charge modulation and hydrolysis reactions [10–13] . These characteristics have spurred growing interest in developing metal-based anticancer agents through this discipline [12, 14] . The beginnings of modern metal-based  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Chemistry –A European Journal published by Wiley-VCH GmbH  \nChemistry –A European Journal, 2026; 32:e03422 1 of 24  \n[https://doi.org/10.1002/chem.202503422](https://doi.org/10.1002/chem.202503422)  \nchemotherapy date back to the year 1844, whe","cbCaikPMAGrL3M3t","https://ap.wps.com/l/cbCaikPMAGrL3M3t","pdf",4254457,24,"English","# Keywords\n## Abstract\n## Introduction","[{\"question\":\"What prodrugs are evaluated in this study and how are they designed?\",\"answer\":\"PtIVP-5FUMeOBut and PtIV56-5FUMeOBut are created by derivatizing 5-fluorouracil and coordinating it to platinum(IV) complexes to combine 5FU’s antimetabolite effects with platinum-based cytotoxicity.\"},{\"question\":\"Which in vitro models and comparisons are used to assess anticancer activity?\",\"answer\":\"The study evaluates in vitro potency in colorectal cancer models, including cellular uptake, cytotoxicity, and effects in 3D spheroid cultures, comparing results with cisplatin and 5FU.\"},{\"question\":\"How are the mechanisms of action investigated?\",\"answer\":\"Mechanistic work includes assays for apoptosis and necrosis, measurements related to reactive oxygen species and mitochondrial membrane potential, cell-cycle progression analysis, proteomic profiling, and western blot analysis of key signaling pathways.\"}]","Chemotherapeutic Potential of Fluorouracil-Platinum (IV) Prodrugs Against Cisplatin-Resistant Colorectal Cancer Cells | PDF",1790112345,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c59087f292f1a96fe331343e096adae.webp",983,1283,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7ad5e7a04aeeba466dc0663a60dcac3.webp",982,1281,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8b73fe7b81a2bba5d39582f81e7aea1.webp",981,1280,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48e32387e8e60cbab52f435e739c48e3.webp",980,1279]